Barclays Maintains Overweight on Sempra, Raises Price Target to $105
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Barclays analyst Nicholas Campanella maintains Sempra (NYSE:SRE) with a Overweight and raises the price target from $95 to $105.
Barclays analyst Nicholas Campanella maintains Sempra (NYSE:SRE) with a Overweight and raises the price target from $95 to $105.